Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Lipids: Dietary Sources and Requirements

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Role of Beta-Blockers in the Treatment of Hypertension.

Advances in experimental medicine and biology·2016

Same author

Hypertensive subjects with type-2 diabetes, the sympathetic nervous system, and treatment implications.

International journal of cardiology·2014

Same author

Evolving strategies for optimal care management and plan benefit designs.

The American journal of managed care·2013

Same author

Don't beta blockers still have a role in hypertension?

BMJ (Clinical research ed.)·2011

Same author

Beta-blockers and heart failure.

Indian heart journal·2010

Same author

Beta blockers in hypertension.

Lancet (London, England)·2010

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

Achieving cholesterol targets: how well are we doing?

John M Cruickshank¹

¹Lovelace Health Plan, 4101 Indian School Rd NE, Albuquerque, NM 87110, USA. john.cruickshank@lovelace.com

The Journal of the American Osteopathic Association

|May 20, 2011

Summary

This summary is machine-generated.

High low-density lipoprotein cholesterol (LDL-C) increases coronary heart disease (CHD) risk. The American Osteopathic Association Clinical Assessment Program aids physicians in improving LDL-C management for better patient outcomes.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Experiment Videos

Last Updated: Jun 1, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Area of Science:

Cardiology
Public Health
Health Services Research

Background:

Elevated low-density lipoprotein cholesterol (LDL-C) is a significant modifiable risk factor for coronary heart disease (CHD).
CHD remains the leading cause of death in the United States, highlighting the need for effective management strategies.
While screening and treatment rates have improved, substantial opportunities for enhancement exist, particularly for high-risk individuals.

Purpose of the Study:

To introduce the American Osteopathic Association Clinical Assessment Program (AOA CAP) as a tool to improve physician performance in managing elevated LDL-C.
To guide treatment decisions for patients with elevated LDL-C levels, aiming to reduce CHD risk.
To enhance outcomes for patients with elevated LDL-C through data-driven clinical assessment.

Main Methods:

Utilizing a Web-based program (AOA CAP) for physician performance measurement.
Analyzing data abstracted from patient medical records.
Guiding treatment decisions based on performance data and patient risk stratification.

Main Results:

The AOA CAP serves as a tool to identify areas for improvement in LDL-C management.
Physician performance data can guide more aggressive and effective LDL-C-lowering therapies.
The program aims to improve patient outcomes by optimizing treatment strategies.

Conclusions:

The AOA CAP is a valuable resource for physicians to enhance the management of elevated LDL-C.
Improved LDL-C control through targeted therapies can significantly reduce CHD events and mortality.
Systematic performance assessment and data-driven guidance are crucial for optimizing cardiovascular risk reduction.